Clay Wilemon

Clay Wilemon serves as the CEO and Chairman of 4L Data Intelligence™ since June 2021, where the focus is on enhancing service quality and reducing costs for healthcare providers and payers through advanced data solutions and patented AI technology. Prior to this role, Clay held the position of Chief Strategy Officer at Brado from October 2019 to May 2021 and was the CEO and Chief Strategy Officer at DevicePharm, Inc. for nearly three decades, from June 1990 to October 2019. Clay is an alumnus of Vanderbilt University, attending from 1979 to 1983.